[1]
“The role of EGFR mutation testing in the choice for surgical tactics in NSCLC treatment”, Вопр. онкол., vol. 67, no. 3, pp. 315–322, Jul. 2021, doi: 10.37469/0507-3758-2021-67-3-315-322.